Showing 1–20 of 33 results
Autoimmune Hepatitis PBMC
Autoimmune Hepatitis PBMC samples are isolated from donors with clinically confirmed autoimmune hepatitis. Ideal for studying T cell–mediated liver inflammation, regulatory immune responses, and autoimmune pathogenesis.
Autoimmune Hepatitis Plasma
Autoimmune Hepatitis Plasma is collected from donors with clinically confirmed autoimmune hepatitis. Useful for analyzing cytokine profiles, liver inflammation markers, and immune system activity.
Autoimmune Hepatitis Serum
Autoimmune Hepatitis Serum is collected from donors with clinically confirmed autoimmune hepatitis. Ideal for detecting liver-specific autoantibodies, immunoglobulin levels, and inflammatory biomarkers.
Autoimmune Hepatitis Whole Blood
Autoimmune Hepatitis Whole Blood is collected from donors with clinically confirmed autoimmune hepatitis. Suitable for transcriptomic analysis, immune cell profiling, and genetic studies related to autoimmune liver disease.
Cirrhosis Leukopak
LeukoCore™ Cirrhosis Leukopak products contain concentrated immune cells from donors with clinically confirmed cirrhosis, collected via apheresis. Ideal for high-yield studies on liver inflammation, immune-mediated fibrogenesis, and immune profiling in chronic liver disease.
Cirrhosis PBMC
Cirrhosis PBMC samples are isolated from donors with clinically confirmed cirrhosis. Ideal for studying immune cell dysfunction, chronic liver inflammation, and the immunopathogenesis of liver fibrosis.
Cirrhosis Plasma
Cirrhosis Plasma samples are collected from donors diagnosed with cirrhosis. Suitable for analyzing liver-derived biomarkers, cytokine profiles, and indicators of hepatic and systemic inflammation.
Cirrhosis Serum
Cirrhosis Serum samples are derived from donors with confirmed cirrhosis. Useful for measuring liver enzymes, fibrosis markers, and immune mediators associated with disease progression and liver failure.
Cirrhosis Whole Blood
Cirrhosis Whole Blood samples are obtained from donors with clinically diagnosed cirrhosis. Valuable for comprehensive immune profiling, gene expression analysis, and exploring hematologic changes linked to chronic liver disease.
Nonalcoholic Fatty Liver Disease Leukopak
LeukoCore™ Nonalcoholic Fatty Liver Disease Leukopak products contain concentrated immune cells from donors with clinically confirmed nonalcoholic fatty liver disease (NAFLD), collected via apheresis. Ideal for high-yield studies on liver inflammation, metabolic-immune interactions, and biomarker discovery in fatty liver disorders.
Nonalcoholic Fatty Liver Disease PBMC
Nonalcoholic Fatty Liver Disease PBMC samples are isolated from donors with clinically confirmed Nonalcoholic Fatty Liver Disease (NAFLD). Ideal for investigating immune cell dysfunction, inflammation, and metabolic signaling involved in hepatic steatosis and disease progression.
Nonalcoholic Fatty Liver Disease Plasma
Nonalcoholic Fatty Liver Disease Plasma samples are collected from donors diagnosed with Nonalcoholic Fatty Liver Disease (NAFLD). Suitable for analyzing circulating biomarkers such as ALT, AST, adipokines, cytokines, and markers of insulin resistance and liver fibrosis.
Nonalcoholic Fatty Liver Disease Serum
Nonalcoholic Fatty Liver Disease Serum samples are derived from donors with confirmed Nonalcoholic Fatty Liver Disease (NAFLD). Useful for evaluating liver enzymes, lipid profiles, inflammatory markers, and fibrosis-related proteins to support biomarker discovery and clinical stratification.
Nonalcoholic Fatty Liver Disease Whole Blood
Nonalcoholic Fatty Liver Disease Whole Blood samples are obtained from donors with clinically diagnosed Nonalcoholic Fatty Liver Disease (NAFLD). Valuable for transcriptomic and genomic analysis, immune profiling, and identifying systemic contributors to metabolic liver disease.
Nonalcoholic Steatohepatitis PBMC
Nonalcoholic Steatohepatitis PBMC samples are isolated from donors with clinically confirmed Nonalcoholic Steatohepatitis (NASH). Ideal for studying immune dysregulation, inflammation, and fibrogenic signaling pathways involved in NASH progression.
Nonalcoholic Steatohepatitis Plasma
Nonalcoholic Steatohepatitis Plasma samples are collected from donors diagnosed with Nonalcoholic Steatohepatitis (NASH). Suitable for analyzing circulating biomarkers such as ALT, AST, CK-18, and inflammatory cytokines associated with NASH and liver fibrosis.
Nonalcoholic Steatohepatitis Serum
Nonalcoholic Steatohepatitis Serum samples are derived from donors with confirmed Nonalcoholic Steatohepatitis (NASH). Useful for profiling liver enzymes, lipid metabolism markers, and systemic indicators of hepatic inflammation and steatosis in NASH.
Nonalcoholic Steatohepatitis Whole Blood
Nonalcoholic Steatohepatitis Whole Blood samples are obtained from donors with clinically diagnosed Nonalcoholic Steatohepatitis (NASH). Valuable for gene expression studies, immune cell profiling, and identifying molecular signatures driving NASH-related liver damage.
PFIC PBMC
PFIC PBMC samples are isolated from donors with clinically and genetically confirmed Progressive Familial Intrahepatic Cholestasis (PFIC). Ideal for studying immune responses, hepatocellular transport defects, and inflammatory pathways contributing to cholestasis in PFIC.
PFIC Plasma
PFIC Plasma samples are collected from donors diagnosed with Progressive Familial Intrahepatic Cholestasis (PFIC). Suitable for analyzing bile acid profiles, liver injury markers, and cytokines associated with disease severity and progression in PFIC.